Inspira Technologies appoints Glo-Med as primary U.S. distributor

Inspira Technologies (IINN) has entered into an agreement with Glo-Med Networks , which will serve as Inspira’s primary distributor in the U.S. Glo-Med’s distribution facility will serve as a support center for the deployment of the INSPIRA ART100 in the U.S. The INSPIRA ART100 is FDA 510(k)-cleared for Cardiopulmonary Bypass procedures. Toward the planned deployment of the INSPIRA ART100 in 2024 and looking ahead, the company’s goal is to introduce physicians and perfusionists to Inspira’s technologies and brand proposition in preparation for the future planned deployment of the flagship INSPIRA ART. The distribution facility, located in Florida, will potentially facilitate the commercialization of additional products in the U.S. market in the future. The medical distribution and service facility will be fully operated by Glo-Med and will serve as a central hub for Inspira’s logistics operations. Additionally, the facility will provide original equipment manufacturer certified after-market services through a partnership with Med-Stat Consulting Services), a national biomedical engineering services firm founded in 2003.